{
  "symbol": "REGN",
  "name": "Regeneron Pharmaceuticals",
  "cik": "0000872589",
  "years": [
    2020,
    2021,
    2022,
    2023,
    2024
  ],
  "yearly_fs": {
    "2020": {
      "operating_income": 3576600000.0,
      "net_income": 1149200000.0,
      "rnd_expense": 2647000000.0,
      "sga_expense": 1346000000.0,
      "interest_expense": 56900000.0,
      "income_tax_expense": 297200000.0,
      "total_assets": 17163300000.0,
      "total_liabilities": 6138000000.0,
      "total_equity": 11025300000.0,
      "current_assets": 9779100000.0,
      "current_liabilities": 2697400000.0,
      "cash_and_equiv": 2193700000.0,
      "long_term_debt": 1978500000.0,
      "accounts_receivable": 4114700000.0,
      "inventory": 1916600000.0,
      "cfo": 2618100000.0,
      "cfi": -70600000.0,
      "cff": -1970500000.0,
      "depr_amort": 235900000.0,
      "share_repurchases": 5846800000.0
    },
    "2021": {
      "operating_income": 8946800000.0,
      "net_income": 8075300000.0,
      "rnd_expense": 2860100000.0,
      "sga_expense": 1824900000.0,
      "interest_expense": 57300000.0,
      "income_tax_expense": 1250500000.0,
      "total_assets": 25434800000.0,
      "total_liabilities": 6666000000.0,
      "total_equity": 18768800000.0,
      "current_assets": 14014900000.0,
      "current_liabilities": 3932500000.0,
      "cash_and_equiv": 2885600000.0,
      "long_term_debt": 1980000000.0,
      "accounts_receivable": 6036500000.0,
      "inventory": 1951300000.0,
      "cfo": 7081300000.0,
      "cfi": -5384700000.0,
      "cff": -1005800000.0,
      "depr_amort": 286200000.0,
      "share_repurchases": 1645400000.0
    },
    "2022": {
      "operating_income": 4738900000.0,
      "net_income": 4338400000.0,
      "rnd_expense": 3592500000.0,
      "sga_expense": 2115900000.0,
      "interest_expense": 59400000.0,
      "income_tax_expense": 520400000.0,
      "total_assets": 29214500000.0,
      "total_liabilities": 6550500000.0,
      "total_equity": 22664000000.0,
      "current_assets": 15884100000.0,
      "current_liabilities": 3141300000.0,
      "cash_and_equiv": 3105900000.0,
      "long_term_debt": 1981400000.0,
      "accounts_receivable": 5328700000.0,
      "inventory": 2401900000.0,
      "cfo": 5014900000.0,
      "cfi": -3784600000.0,
      "cff": -1009000000.0,
      "depr_amort": 341400000.0,
      "share_repurchases": 2082800000.0
    },
    "2023": {
      "operating_income": 4047100000.0,
      "net_income": 3953600000.0,
      "rnd_expense": 4439000000.0,
      "sga_expense": 2631300000.0,
      "interest_expense": 73000000.0,
      "income_tax_expense": 245700000.0,
      "total_assets": 33080200000.0,
      "total_liabilities": 7107100000.0,
      "total_equity": 25973100000.0,
      "current_assets": 19479200000.0,
      "current_liabilities": 3423400000.0,
      "cash_and_equiv": 2730000000.0,
      "long_term_debt": 1982900000.0,
      "accounts_receivable": 5667300000.0,
      "inventory": 2580500000.0,
      "cfo": 4594000000.0,
      "cfi": -3185100000.0,
      "cff": -1790100000.0,
      "depr_amort": 421000000.0,
      "share_repurchases": 2235000000.0
    },
    "2024": {
      "operating_income": 3990700000.0,
      "net_income": 4412600000.0,
      "rnd_expense": 5132000000.0,
      "sga_expense": 2954400000.0,
      "income_tax_expense": 367300000.0,
      "total_assets": 37759400000.0,
      "total_liabilities": 8405800000.0,
      "total_equity": 29353600000.0,
      "current_assets": 18660900000.0,
      "current_liabilities": 3944300000.0,
      "cash_and_equiv": 2488200000.0,
      "long_term_debt": 1984400000.0,
      "accounts_receivable": 6211900000.0,
      "inventory": 3087300000.0,
      "cfo": 4420500000.0,
      "cfi": -2468100000.0,
      "cff": -2200500000.0,
      "depr_amort": 482900000.0,
      "share_repurchases": 2603300000.0
    }
  }
}